Tags: Drug.

Cefdinir is a third generation oral cephalosporin antibiotic. It was discovered by Fujisawa Pharmaceutical Co. Ltd. Fujisawa (now Astellas) and introduced in 1991 under the brand name Cefzon. Warner-Lambert licensed this cephalosporin cefdinir for marketing in US from Fujisawa Japan. Abbott obtained U.S. marketing rights to Omnicef (Cefdinir) in December 1998 through an agreement with Warner-Lambert Company. It was approved by FDA on Dec 4 1997.

Cefdinir.svg
ATC prefix
J01
ATC suffix
DD15
Bioavailability
16.0
CAS number
91832-40-5
ChEBI
3485
DrugBank
DB00535
FDA UNII code
CI0FAO63WC
IUPAC name
azabicyclo[4.2.0]oct-4-ene-5-carboxylic acid, ethenyl]amino-4-ethenyl-7-oxo-2-thia-6-, 8-[2-(2-amino-13-thiazol-4-yl)-1-hydroxy-2-nitroso-
PubChem
6915944

Loading...

This page contains content from the copyrighted Wikipedia article "Cefdinir"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.